To understand the real impact of COVID-19 on cancer patients, an entirely new data collection effort was initiated within the Thoracic Cancers International COVID-19 Collaboration (TERAVOLT). TERAVOLT reported high mortality related to COVID-19 infection in thoracic cancer patients and identified several negative prognostic factors. In this commentary, we discuss the importance and limits of patient registries to support decision-making in thoracic cancer during the SARS-CoV-2 pandemic.

中文翻译：

---

通过全球研究承诺支持SARS-CoV-2大流行期间的临床决策：TERAVOLT经验

为了了解COVID-19对癌症患者的真正影响，国际胸腔癌国际COVID-19协作组织（TERAVOLT）发起了全新的数据收集工作。TERAVOLT报告了在胸癌患者中与COVID-19感染相关的高死亡率，并确定了一些不良预后因素。在这篇评论中，我们讨论了在SARS-CoV-2大流行期间支持患者决策的患者注册表的重要性和局限性。